During tumor formation, intracellular M2-type pyruvate kinase (PKM2) is abundantly expressed in place of the original tissue-specific pyruvate kinase isoform until it becomes the predominant isoform (Chaneton and Gottlieb, 2012). The gene discussed is PKM; the disease is neoplasm.